Enzon and Viskase amend merger agreement terms
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500, Nasdaq set for higher open as investors weigh weaker oil, PPI data
- Oil falls on weaker demand outlook and higher US stocks
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Enzon and Viskase Announce Amendment to Merger Agreement
October 24, 2025 4:50 PM EDTCRANFORD, N.J. and LOMBARD, Ill., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (Enzon or the Company) and Viskase Companies, Inc. (OTC Pink Limited: VKSC) (Viskase) today announced that they have entered into an amendment (the Amendment) to the previously disclosed Agreement and Plan of Merger (the Merger Agreement), pursuant to which Viskase will merge with and into a wholly owned subsidiary of Enzon in an all-stock transaction (the Merger). The Amendment was entered into to reflect recent developments in the operations of Viskase during the past several... More
